Cariescan, the dental technology group formed out of university spinout, IDMOS, has raised £750,000, its second fundraising this year. The Dundee based company said the cash, raised from existing shreholders including Scottish Enterprise, would be used for research and marketing investment.
Chief Executive Graham Lay said Cariescan’s first product, which it claims measures tooth decay more accurately than X-Rays, is now on sale in the UK, while a distribution agreement for Canada is imminent.
The DC Consulting team, led by Angus Hay, has successfully assisted NovaBiotics Limited in securing an equity investment of £1.1 million. The investment was made by both existing shareholders in the company and by new sources of funds introduced by DC Consulting, including Discovery Investment Fund, TRIcap and Aurora Private Equity. After the successful completion of the transaction, NovaBiotics announced regulatory and ethics clearance had been obtained to commence clinical trials of its lead product Novexatin.
Co-ordinated by DC Consulting’s John Craig, PowerPhotonic has recently been awarded a £80,000 RSA award to support a ramp up in production and sales activity. This grant award augments a £325,000 investment into the company led by Archangel Informal Investments and Tri Capital.
In a transaction co-ordinated by John Craig, J Funerals Limited have successfully completed the SEED investment to launch its products in the funeral market place.
This investment brings together Sandra Thomson, who has worked in the Jute Industry since 1985 (and widely accepted as an expert in this field), and David McKenzie, previous founder and CEO of Commsworld Limited with the primary aim of delivery eco-friendly coffins and associated funereal products to the mainstream market.
CarieScan secures £2 million for global sales & marketing.CarieScan, based in Dundee, is taking to market a device which uses AC impedance spectroscopy (ACIST) to determine the mineral density of dental substrate, as a means of detecting tooth decay at an earlier stage than usual, and monitoring its progress accurately.